Home > Semiconductors & Electronics > Automation > Industrial Automation > Mass Flow Controller Market
The evolution of sensor technologies has led to significant improvements in the accuracy and responsiveness of MFCs. Innovations in thermal sensors, Coriolis flow sensors, and MEMS (Micro-Electro-Mechanical Systems) have enhanced the capability of MFCs to measure and control flow rates with greater precision and stability. These advanced sensors provide faster response times and higher sensitivity, crucial for applications requiring ultra-low flow rates and high accuracy, such as medical devices and analytical instrumentation.
For instance, in September 2023, Brooks Instrument, a leading manufacturer of precision fluid measurement and control solutions, has announced the launch of its new Quantim QMC series of Coriolis mass flow controllers designed for low-flow, high-accuracy applications. The Quantim QMC series is ideal for applications requiring ultra-precise direct mass flow measurement, such as vacuum processes, catalyst research, and precision coating.
The biopharmaceutical industry is increasingly relying on mass flow controllers due to their critical role in maintaining the precision and quality of manufacturing processes. MFCs are essential for controlling the flow of gases and liquids in biopharmaceutical production, including cell culture processes, fermentation, and filtration. For example, In January 2024, Tokyo Keiso Co., Ltd. introduced two new flowmeters—BIOMAG Electromagnetic Flowmeter and BIOSONIC Ultrasonic Flowmeter—specifically designed for single-use biopharmaceutical applications.
These innovative flowmeters feature disposable flow sensors that ensure biocompatibility and can withstand gamma-ray sterilization. The products are crafted in cleanroom environments and come with single-barb fittings, aligning with the industry's strict standards for contamination control and process integrity. This launch highlights the growing market demand for specialized MFC solutions that cater to the unique needs of biopharmaceutical manufacturing.